1.36
price up icon8.80%   0.11
after-market 시간 외 거래: 1.34 -0.02 -1.47%
loading
전일 마감가:
$1.25
열려 있는:
$1.22
하루 거래량:
1.19M
Relative Volume:
2.02
시가총액:
$111.06M
수익:
-
순이익/손실:
$-166.14M
주가수익비율:
-0.7047
EPS:
-1.93
순현금흐름:
$-139.92M
1주 성능:
+11.48%
1개월 성능:
+97.10%
6개월 성능:
+17.24%
1년 성능:
-39.56%
1일 변동 폭
Value
$1.22
$1.40
1주일 범위
Value
$1.19
$1.408
52주 변동 폭
Value
$0.535
$3.405

Allakos Inc Stock (ALLK) Company Profile

Name
명칭
Allakos Inc
Name
전화
650-597-5002
Name
주소
825 INDUSTRIAL ROAD, SAN CARLOS, CA
Name
직원
131
Name
트위터
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
ALLK's Discussions on Twitter

Allakos Inc Stock (ALLK) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-01-17 다운그레이드 Jefferies Buy → Hold
2024-01-16 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2023-12-18 업그레이드 William Blair Mkt Perform → Outperform
2023-12-08 재개 Jefferies Buy
2023-09-27 개시 JMP Securities Mkt Outperform
2023-05-12 업그레이드 Jefferies Hold → Buy
2023-03-07 개시 Piper Sandler Overweight
2022-09-12 다운그레이드 SMBC Nikko Neutral → Underperform
2021-12-22 다운그레이드 BofA Securities Buy → Underperform
2021-12-22 다운그레이드 Cowen Outperform → Market Perform
2021-12-22 다운그레이드 Jefferies Buy → Hold
2021-12-22 다운그레이드 SVB Leerink Outperform → Mkt Perform
2021-12-22 다운그레이드 William Blair Outperform → Mkt Perform
2021-08-26 개시 Morgan Stanley Equal-Weight
2021-07-15 개시 Cowen Outperform
2021-05-18 개시 H.C. Wainwright Buy
2021-02-24 개시 Cantor Fitzgerald Overweight
2021-01-15 개시 BofA Securities Buy
2020-12-21 개시 SVB Leerink Outperform
2020-02-27 개시 Barclays Underweight
2020-02-04 재개 Goldman Neutral
2018-08-13 개시 Goldman Neutral
2018-08-13 개시 Jefferies Buy
2018-08-13 개시 William Blair Outperform
모두보기

Allakos Inc 주식(ALLK)의 최신 뉴스

pulisher
Nov 04, 2024

Urticaria Clinical Trial Pipeline Accelerates: 20+ Leading Companies Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.

Nov 04, 2024
pulisher
Oct 28, 2024

Allakos Inc. (NASDAQ:ALLK) Short Interest Down 17.1% in October - MarketBeat

Oct 28, 2024
pulisher
Oct 22, 2024

3 US Penny Stocks With Market Caps Larger Than $50M - Simply Wall St

Oct 22, 2024
pulisher
Oct 22, 2024

Allakos Insiders Miss 24% Gain After Offloading Stock - Simply Wall St

Oct 22, 2024
pulisher
Oct 21, 2024

Vernal Keratoconjunctivitis Market Growth to Accelerate - openPR

Oct 21, 2024
pulisher
Oct 17, 2024

The Manufacturers Life Insurance Company Sells 2,148 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World

Oct 17, 2024
pulisher
Oct 17, 2024

Short Interest in Custom Truck One Source, Inc. (NYSE:CTOS) Decreases By 5.5% - Defense World

Oct 17, 2024
pulisher
Oct 16, 2024

Nasal Polyposis Market Size is Set for Rapid Growth as Innovative - openPR

Oct 16, 2024
pulisher
Oct 15, 2024

Chronic Spontaneous Urticaria Market Forecasted to Surge - openPR

Oct 15, 2024
pulisher
Oct 14, 2024

Jefferies downgrades Allakos Inc (ALLK) stock to a Hold - Knox Daily

Oct 14, 2024
pulisher
Oct 14, 2024

Allakos Inc (ALLK)’s stock price range in the last year - US Post News

Oct 14, 2024
pulisher
Oct 14, 2024

Investor’s Delight: Allakos Inc (ALLK) Closes Weak at 0.65, Down -1.14 - The Dwinnex

Oct 14, 2024
pulisher
Oct 12, 2024

Allakos shares hold rating after trial update By Investing.com - Investing.com Australia

Oct 12, 2024
pulisher
Oct 12, 2024

Piper Sandler maintains Overweight rating on Allakos shares By Investing.com - Investing.com Australia

Oct 12, 2024
pulisher
Oct 11, 2024

TD Cowen Reiterates Hold Rating on Allakos Inc. (ALLK) - StreetInsider.com

Oct 11, 2024
pulisher
Oct 11, 2024

Piper Sandler maintains Overweight rating on Allakos shares - Investing.com India

Oct 11, 2024
pulisher
Oct 11, 2024

Allakos shares hold rating after trial update - Investing.com

Oct 11, 2024
pulisher
Oct 11, 2024

Allakos stock gains on trial data for lead drug (NASDAQ:ALLK) - Seeking Alpha

Oct 11, 2024
pulisher
Oct 11, 2024

Piper Sandler Reiterates Overweight Rating on Allakos Inc. (ALLK) - StreetInsider.com

Oct 11, 2024
pulisher
Oct 10, 2024

Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers - ForexTV.com

Oct 10, 2024
pulisher
Oct 10, 2024

Allakos reports positive results from AK006 Phase 1 study - Investing.com India

Oct 10, 2024
pulisher
Oct 10, 2024

Allakos Progress Update on AK006 and Future Milestones - TipRanks

Oct 10, 2024
pulisher
Oct 10, 2024

Allakos reports positive results from AK006 Phase 1 study By Investing.com - Investing.com UK

Oct 10, 2024
pulisher
Oct 10, 2024

Allakos (ALLK) Reports Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers - StreetInsider.com

Oct 10, 2024
pulisher
Oct 08, 2024

SG Americas Securities LLC Grows Stake in Stellantis (NYSE:STLA) - Defense World

Oct 08, 2024
pulisher
Sep 30, 2024

Vernal Keratoconjunctivitis Market to Show Remarkable Growth - openPR

Sep 30, 2024
pulisher
Sep 30, 2024

Vernal Keratoconjunctivitis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Santen SAS, Novartis, Laboratoires Thea, Allakos Inc., Santen SASl, Astellas Pharma Inc - Barchart

Sep 30, 2024
pulisher
Sep 29, 2024

Duff & Phelps Investment Management Co. Cuts Holdings in Enbridge Inc. (NYSE:ENB) - Defense World

Sep 29, 2024
pulisher
Sep 28, 2024

Allakos (ALLK): Strong Industry, Solid Earnings Estimate Revisions - MSN

Sep 28, 2024
pulisher
Sep 27, 2024

Wall Street SWOT: Allakos stock faces pivotal year as AK006 data looms - Investing.com

Sep 27, 2024
pulisher
Sep 26, 2024

Allakos (NASDAQ:ALLK) Receives Market Outperform Rating from JMP Securities - MarketBeat

Sep 26, 2024
pulisher
Sep 23, 2024

Leerink Partners analysts initates a Market perform rating for Align Technology, Inc. (ALGN) - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Defense Stock Soars on ‘Rare Move’ From the U.S. Army - Barron's

Sep 23, 2024
pulisher
Sep 23, 2024

French InsurTech Alan raises $193m to bolster tech and growth in Belgium - FinTech Global

Sep 23, 2024
pulisher
Sep 23, 2024

Allied Properties Real Estate Investment Trust (TSE:AP.UN) Price Target Increased to C$18.50 by Analysts at Canaccord Genuity Group - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Aligos Therapeutics (NASDAQ:ALGS) Reaches New 52-Week Low at $8.28 - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Allogene Therapeutics Inc [ALLO] Stock bought by Insider Douglas Earl Martin for $78844.0 - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Alignment Healthcare (NASDAQ:ALHC) Shares Gap Down to $11.43 - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Investing in Alta Equipment Group Inc (ALTG): What You Must Know - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Allegion Stock: Is ALLE Outperforming The Industrials Sector? - Barchart

Sep 23, 2024
pulisher
Sep 23, 2024

Alumis Inc. [ALMS] Stock bought by Insider Foresite Labs, LLC for $40.0 million - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Altitude Group’s AGM: Mixed Shareholder Decisions - TipRanks

Sep 23, 2024
pulisher
Sep 23, 2024

Views of Wall Street’s Leading Experts on Alta Equipment Group Inc - SETE News

Sep 23, 2024
pulisher
Sep 23, 2024

Trading Day Triumph: Allogene Therapeutics Inc (ALLO) Ends at 2.80, a -3.78 Surge/Plunge - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Ally Bridge Group NY LLC Reduces Holdings in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Alternus Clean Energy outlines plan to regain Nasdaq compliance - Proactive Investors Australia

Sep 23, 2024
pulisher
Sep 23, 2024

Canada Pension Plan Investment Board Has $25.79 Million Position in Align Technology, Inc. (NASDAQ:ALGN) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

LKQ Co. (NASDAQ:LKQ) Shares Acquired by Lombard Odier Asset Management Europe Ltd - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Allakos Inc (ALLK)’s results reveal risk - US Post News

Sep 23, 2024
pulisher
Sep 23, 2024

ALLO underperforms with a -3.78 decrease in share price - US Post News

Sep 23, 2024
pulisher
Sep 23, 2024

An Analysis of Alkami Technology Inc (ALKT)’s Potential Price Growth - Knox Daily

Sep 23, 2024

Allakos Inc (ALLK) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
자본화:     |  볼륨(24시간):